Navigation Links
EVS™ vascular stapling system

ProductsEVS™ vascular stapling system
Company Medtronic Inc.
Item EVS™ vascular stapling system
Features The stapler is nserted through the delivery sheath to the arterotonym then the trigger is activated. The staple expands to maximixe the amount of adventitia and media to be approximated and closes the vessel. With only a three millimeter diameter, the staple allows for re-access to the vessel site proximity.
Description The EVS is engineered to close arteriotomies with ease and precision. The ergonomic stapler with a simple trigger actvated mechanism, requires a single operator. A deliver sheath gently locks onto the target vessel and maintains control of the site before, during, and after the delivery of an amazing staple.
Info Medtronic Inc.
Customer Service: (800) 551-5544
Web site: http://www.medtronic.com/

Related medicine products :

1. ACE Kinetic Hypertension / Cardiac Evaluation, Cardiovascular 001-KK-ACK4 Angiotensin Converting Enzyme
2. ACE Kinetic Hypertension / Cardiac Evaluation, Cardiovascular 001-KK-ACK Angiotensin Converting Enzyme
3. ACE Kinetic Hypertension / Cardiac Evaluation, Cardiovascular 001-KK-ACKX Angiotensin Converting Enzyme
4. ACTH EIA Hypertension / Cardiac Evaluation, Cardiovascular 021-SDX018
5. Myoglobin EIA Lipid / Protein Quantification, Cardiovascular 024-IDC-13 Muscle Disease
6. Myoglobin RIA Lipid / Protein Quantification, Cardiovascular 024-IDC-11 Muscle Disease
7. Angiotensin II RIA Hypertension / Cardiac Evaluation, Cardiovascular 001-RK-A22
8. Vitamin B6 Jumbo REA Vitamin Assays, Cardiovascular 001-RK-VB6N
9. Vitamin B6 REA Vitamin Assays, Cardiovascular 001-RK-VB6
10. Cortisol EIA Hypertension / Cardiac Evaluation, Cardiovascular 012-MDKCO1 Stress Hormones
11. ACE - REA Hypertension / Cardiac Evaluation, Cardiovascular 001-RK-ACD Angiotensin Converting Enzyme
Liquid Assayed and Unassayed Multiqual Controls are comprehensive, liquid, human serum based chemistry controls, available in three levels.
Lyphochek Benzo/TCA Control Set B is ideal for monitoring HPLC methods for identification and quantitation of benzodiazepines and antidepressant drugs.
Lyphochek Whole Blood Metals Control contains the major heavy metals of toxicological and environmental importance for whole blood analysis.
Lyphochek Urine Metals Control incorporates two levels of critical trace elements, heavy metals and organic metabolites, and is ideal for environmental and industrial testing.
Medicine Products:
(Date:7/25/2008)... - 180-Days of Marketing Exclusivity Begins -,...- Watson,Pharmaceuticals, Inc. (NYSE: WPI ), a le...today that its subsidiary has commenced commercial...es USP product in the 40mg,strength from its Davie...ith the launch, Watson has 180 days of marketing e...
(Date:7/25/2008)...URG, Ill., July 25 /PRNewswire/ -- Sagent Pharmace...utical company, today announced that it,has launch...arrhythmic,indicated for the treatment and prophyl...ion and hemodynamically unstable ventricular,tachy... heart beat.,Sagent,s amiodarone HCl injection wil...
(Date:7/25/2008)...D, Calif., July 25 /PRNewswire/ -- AutoGenomics, I...on statement on Form S-1 with the,Securities and E...l public,offering of shares of its common stock. T... all of which are expected to be offered by,AutoGe..., have not yet been,determined., J.P. Morgan Secu...
(Date:7/25/2008)... New program delivers immediate cost...4-hour telephone access to language interpreters] ...multilingual solutions. , ...E® http://www.lle-inc.com/index.html [(Langu...er of interpretation, translation, and language in...
Breaking Medicine News(10 mins):Health News:Watson Launches Omeprazole Delayed-Release Capsules, 40MG 2Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 2Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 3Health News:AutoGenomics, Inc. Files Registration Statement for Initial Public Offering 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 3
...tool to treat drug-resistant HIV thanks to a new m...// "There are many treatments for AIDS on the mark...said Arun Ghosh (pronounced A-rune GO-sh), a profe...partments of chemistry and medicinal chemistry and...
...ffer from stress urinary incontinence (SUI), a con...an lead to urine leakage.// “We try to treat pati... better bladder habits, doing Kegel exercises, and...coughing, infections and hormone deficiencies—all ...
...ndometrial cancer should be screened for inherited...al other cancers.// The study showed that 1.8 per...etrial cancer patients have mutations for Lynch sy...wn as hereditary nonpolyposis colon cancer, or HNP...
...-borne viruses is well known; a bite on the body t...od stream. But what happens next that causes the v...searchers led by a Howard Hughes Medical Institute...been able to point at a genetic element which help...
Other Medicine News:Health News:Research Leads to First Treatment for Drug-Resistant HIV 2Health News:Research Leads to First Treatment for Drug-Resistant HIV 3Health News:Research Leads to First Treatment for Drug-Resistant HIV 4Health News:Uterine Cancer May be Clue to Inherited Syndrome 2Health News:Uterine Cancer May be Clue to Inherited Syndrome 3Health News:The Dengue Virus Unplugged 2Health News:The Dengue Virus Unplugged 3
(Date:7/23/2008)...E, July 23 /- Dendreon Corp...xpects the Independent Data,Monitoring Committee (...is,of overall survival relating to the Company,s P...cinoma Treatment, also known as D9902B) clinical t...e Company,s investigational,active cellular immuno...
(Date:7/22/2008)...ng efficacy results from a multi-center 293-patien... Toronto Stock Exchange Symbol: CYT, MONTREAL, Ju...ogies,Inc., the global leader in cryotherapy produ...that results previously presented from three,Europ..., Arctic Front(R),were published earlier today in...
(Date:7/22/2008)... Meeting to Discuss Development Plan Completed Suc...irstCall/ -- Amarin Corporation,plc (NASDAQ: AMRN...ith,officials at the U.S. Food and Drug Administra...op AMR101 for the treatment of,hypertriglyceridemi...ceeding to Phase 3 with AMR101 in hypertriglycerid...
(Date:7/22/2008)...imens Including Lantus(R) and Apidra(R) Resulted i...Type 2 Diabetes, Whatever the Algorithm ...uly 22 /- Results from the "Adjust to... Algorithm to Carbohydrate,Counting for Adjustment...hed in the American Diabetes Association,s (ADA) m...
Breaking Medicine Technology:Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4CryoCath Arctic Front(R) Results Published in JACC 2CryoCath Arctic Front(R) Results Published in JACC 3Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 2Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 4March of Dimes Announces Nursing Scholarship Recipients 23384 1March of Dimes Announces Nursing Scholarship Recipients 23384 2March of Dimes Announces Nursing Scholarship Recipients 23384 3March of Dimes Announces Nursing Scholarship Recipients 23384 4Biodiversity maps developed by UCSD scientists will help guide conservation measures in East Africa 3920 1Biodiversity maps developed by UCSD scientists will help guide conservation measures in East Africa 3920 2Biodiversity maps developed by UCSD scientists will help guide conservation measures in East Africa 3920 3Zix Corporation Announces Webcast Showcasing Email Encryption Competitive Replacement 23376 1Zix Corporation Announces Webcast Showcasing Email Encryption Competitive Replacement 23376 2Researchers reveal types of genes necessary for brain development 3919 1Researchers reveal types of genes necessary for brain development 3919 2
...K, April 10, 2007 /PRNewswire-FirstCall/ -- ImClon...mpany today,announced that a Phase III study of ER...apy) in patients with locally advanced,unresectabl...,primary endpoint of improving overall survival. ,... a cancer,center network sponsored by the National...
...TO, Calif., April 09, 2007 /PRNewswire-FirstCall/ ...a from its,multicenter Phase 2 trial of the triple...286), carboplatin and paclitaxel will be,presented...ation,for Cancer Research (AACR) in Los Angeles. P...lates of synergistic cancer cell growth,inhibition...
Other Medicine Technology:Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 2Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 3Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 4Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 5Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 6Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 7Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 8Data Available from Erbitux Phase III Study in First-Line Treatment,of Advanced Pancreatic Cancer 9Telik Announces Telcyta Clinical and Preclinical Presentations at,AACR Meeting 2Telik Announces Telcyta Clinical and Preclinical Presentations at,AACR Meeting 3